Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm Exceeds First Monsanto Milestone

Premium

RESEARCH TRIANGLE PARK, NC--Paradigm Genetics, announced that it has exceeded by 20 percent the first milestone in its $55 million collaboration agreement with Monsanto (now known as Pharmacia) in the field of functional genomics. By exceeding this milestone, Paradigm will receive an accelerated milestone payment.

 

Paradigm is using its GeneFunction Factory to determine the function of genes selected by Pharmacia for use in future products. Paradigm will share in product revenues generated through this collaboration in the form of product milestone payments and royalties.

Filed under

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.